TRANILAST AMELIORATES RENAL TUBULAR DAMAGE IN UNILATERAL URETERAL OBSTRUCTION
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (5) , 1714-1718
- https://doi.org/10.1016/s0022-5347(05)66400-2
Abstract
We determined whether tranilast, the anti-allergic agent N-(3, 4-dimethoxyciannamoyl)-anthranilic acid, would diminish renal transforming growth factor-β (TGF-β) levels in unilateral ureteral obstruction and concomitantly affect renal tubular apoptosis and proliferation in that condition. Tranilast (150 mg./kg.) was administered to rats 1 day before unilateral ureteral obstruction and each day thereafter. Kidneys were harvested day 14 after unilateral ureteral obstruction. Tissue TGF-β was measured by bioassay using mink lung epithelial cells. Renal tubular proliferation and apoptosis were detected by immunostaining proliferating cell nuclear antigen and the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay, respectively. Fibrosis was assessed by measuring collagen deposition with trichrome stained slides. TGF-β bioassay showed that obstructed kidneys in controls contained significantly higher mean TGF-β plus or minus standard deviation than unobstructed kidneys in controls (73.7 ± 13.6 versus 14.1 ± 5.5 pg./mg. tissue) and tranilast significantly decreased tissue TGF-β in obstructed kidneys (15.9 ± 4.8 pg./mg. tissue). The terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay demonstrated that obstructed kidneys in controls had significantly more mean tubular apoptosis than the unobstructed counterparts (36.6 ± 6.7 versus 5.8 ± 5.5 nuclei per high power field) and tranilast significantly decreased mean renal tubular apoptosis in obstructed kidneys (16.2 ± 1.7 nuclei per high power field). In addition, immunostaining proliferating cell nuclear antigen showed that obstructed kidneys in controls had significantly more mean renal tubular proliferation than unobstructed kidneys (20.7 ± 3.4 versus 6.2 ± 2.1 per high power field) and tranilast significantly increased proliferating renal tubules in obstructed and unobstructed kidneys (26.5 ± 8.3 and 14.5 ± 3.4 per high power field, respectively). Control obstructed kidneys exhibited significantly more fibrosis, which was also blunted by tranilast. Tranilast significantly decreases tissue TGF-β, resulting in a reduction in tubular apoptosis and an increase in tubular proliferation. This finding suggests that tranilast is a promising agent for preventing renal tubular damage in unilateral ureteral obstruction.Keywords
This publication has 16 references indexed in Scilit:
- Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstructionKidney International, 2000
- Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factorKidney International, 1998
- Inhibitory Effect of Tranilast on Hypertrophic Collagen Production in the Spontaneously Hypertensive Rat HeartThe Japanese Journal of Pharmacology, 1998
- Inhibitory Effect of Tranilast on Activation and Transforming Growth Factor β1 Expression in Cultured Rat Stellate CellsBiochemical and Biophysical Research Communications, 1996
- Cell apoptosis and proliferation in experimental chronic obstructive uropathyKidney International, 1996
- Inhibitory Action of Tranilast, an Anti-Allergic Drug, on the Release of Cytokines and PGE2 from Human Monocytes-Macrophages.The Japanese Journal of Pharmacology, 1992
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989
- PHARMACOLOGICAL PROPERTIES OF N‐(3′,4′‐DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N‐5′), A NEW ANTI‐ATOPIC AGENTBritish Journal of Pharmacology, 1976
- RELATIONSHIP BETWEEN RENAL FUNCTION AND HISTOLOGICAL CHANGES FOUND IN RENAL-BIOPSY SPECIMENS FROM PATIENTS WITH PERSISTENT GLOMERULAR NEPHRITISThe Lancet, 1968